Condition
Eosinophilic Fasciitis
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Recruiting1
Withdrawn1
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07348263RecruitingPrimary
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
NCT04305678Phase 1WithdrawnPrimary
Mepolizumab for Eosinophilic Fasciitis
NCT05915585Not ApplicableUnknownPrimary
High-Intensity Laser Therapy for Eosinophilic Fasciitis
NCT04752397Completed
The Influence of Extracorporeal Photopheresis on Skin Sclerosis
Showing all 4 trials